vs

Side-by-side financial comparison of Canaan Inc. (CAN) and IRIDEX CORP (IRIX). Click either name above to swap in a different company.

Canaan Inc. is the larger business by last-quarter revenue ($20.8M vs $14.7M, roughly 1.4× IRIDEX CORP).

Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

CAN vs IRIX — Head-to-Head

Bigger by revenue
CAN
CAN
1.4× larger
CAN
$20.8M
$14.7M
IRIX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CAN
CAN
IRIX
IRIX
Revenue
$20.8M
$14.7M
Net Profit
$-3.8M
Gross Margin
99.9%
37.2%
Operating Margin
-15.9%
Net Margin
-18.4%
Revenue YoY
-69.7%
Net Profit YoY
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAN
CAN
IRIX
IRIX
Q4 25
$20.8M
$14.7M
Q3 25
$13.8M
$12.5M
Q2 25
$11.4M
$13.6M
Q1 25
$11.9M
Q4 24
$12.7M
Q3 24
$10.2M
$11.6M
Q2 24
$4.8M
$12.6M
Q1 24
$11.8M
Net Profit
CAN
CAN
IRIX
IRIX
Q4 25
$-3.8M
Q3 25
$-1.5M
$-1.6M
Q2 25
$-11.9M
$-994.0K
Q1 25
$-1.7M
Q4 24
$-834.0K
Q3 24
$-10.4M
$-1.9M
Q2 24
$-5.4M
$-2.7M
Q1 24
$-3.5M
Gross Margin
CAN
CAN
IRIX
IRIX
Q4 25
99.9%
37.2%
Q3 25
99.9%
32.1%
Q2 25
99.9%
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
99.9%
37.3%
Q2 24
99.8%
40.7%
Q1 24
37.9%
Operating Margin
CAN
CAN
IRIX
IRIX
Q4 25
-15.9%
Q3 25
-27.0%
-11.3%
Q2 25
-45.5%
-6.9%
Q1 25
-1.7%
Q4 24
-3.9%
Q3 24
-77.2%
-16.1%
Q2 24
-193.9%
-20.9%
Q1 24
-28.0%
Net Margin
CAN
CAN
IRIX
IRIX
Q4 25
-18.4%
Q3 25
-11.0%
-12.6%
Q2 25
-104.4%
-7.3%
Q1 25
-14.2%
Q4 24
-6.6%
Q3 24
-102.7%
-16.7%
Q2 24
-112.3%
-21.2%
Q1 24
-29.5%
EPS (diluted)
CAN
CAN
IRIX
IRIX
Q4 25
$-0.05
Q3 25
$-0.02
$-0.09
Q2 25
$-0.25
$-0.06
Q1 25
$-0.10
Q4 24
$-0.05
Q3 24
$-0.12
Q2 24
$-0.16
Q1 24
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAN
CAN
IRIX
IRIX
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
$6.2M
Stockholders' EquityBook value
$52.4M
Total Assets
$92.5M
$29.2M
Debt / EquityLower = less leverage
0.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAN
CAN
IRIX
IRIX
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
CAN
CAN
IRIX
IRIX
Q4 25
$6.2M
Q3 25
$6.2M
Q2 25
$6.2M
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
CAN
CAN
IRIX
IRIX
Q4 25
$52.4M
Q3 25
$44.7M
$4.7M
Q2 25
$33.8M
$6.1M
Q1 25
$852.0K
Q4 24
$2.1M
Q3 24
$43.6M
$2.6M
Q2 24
$56.8M
$4.2M
Q1 24
$6.5M
Total Assets
CAN
CAN
IRIX
IRIX
Q4 25
$92.5M
$29.2M
Q3 25
$81.7M
$28.4M
Q2 25
$78.0M
$31.6M
Q1 25
$34.2M
Q4 24
$29.1M
Q3 24
$69.3M
$30.2M
Q2 24
$73.7M
$31.2M
Q1 24
$34.1M
Debt / Equity
CAN
CAN
IRIX
IRIX
Q4 25
0.12×
Q3 25
0.14×
Q2 25
0.18×
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons